Physician profile
Ryan G Miller
NPI 1962445403
$3,361.57
in general payments reported to CMS, 2019-2025
18 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $68.05 · 2021: $450 · 2022: $531 · 2023: $579 · 2024: $1,001 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,003.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $933.14 | 2021-2025 | Oxervate |
| Alcon Vision LLC | $735.99 | 2019-2025 | Tryptyr, Total30, Dailies Total1 |
| Glaukos Corporation | $536.54 | 2021-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $249.18 | 2022-2023 | |
| Harrow Eye, LLC | $187.99 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $154.06 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $114.70 | 2019-2021 | |
| Biotissue Holdings INC. | $86.44 | 2019-2022 | |
| Rxsight INC | $82.12 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Kowa Research Institute, INC. | $79.40 | 2022 | |
| Allergan, INC. | $50.78 | 2021 | |
| Bausch & Lomb Americas INC. | $41.96 | 2024-2025 | Xiidra, Miebo |
| Mallinckrodt Hospital Products INC. | $36.41 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $19.74 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $19.12 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.60 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.